Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) sits in the top decile of US sponsors by registered trial count (#484 of 15,742 sponsors by registered trial count).
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute): 34 sponsored US clinical trials, 13 recruiting.
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) sponsors 34 registered US clinical trials on ClinicalTrials.gov, 13 of them currently recruiting, and 9 completed. 3 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cancer, with 5 trials.
Top-decile sponsor footprint
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) ranks in the top decile of sponsors by registered trial count (#484 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
9 of 17 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (52.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
34 total, page 1 of 1
Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors
NCT07443020
Effect of a Sacral Lift on Femoral Vein Size and Exposure
NCT06916741
Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning
NCT07023887
Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors
NCT07001592
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
NCT06731998
Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer
NCT06858449
Ex Onc SLED: a Study Utilizing a Weighted Sled for Horizontal Resistance Training
NCT06610396
Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer
NCT06016179
EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer
NCT06115486
EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Cancer
NCT06083324
Deep Brain Stimulation Effects In Patients With Opioid Use Disorder
NCT04354077
Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
NCT04597372
ACDF Using Structural Allograft vs. Tritanium C
NCT04388332
Connective Tissue Matrix for Rotator Cuff Tendinopathy
NCT06160427
Intercostal Nerve Cryotherapy in Patients Undergoing Minimally Invasive Pulmonary Resection
NCT05348447
A Phase II Study of Pre-Op SRS Followed by Surgical Resection for Brain Metastases
NCT05341739
A Study to Evaluate Routine Chest Tube Management After Minimally Invasive Lung Surgery
NCT04913415
Home Biofeedback or Pelvic Floor Physical Therapy for Postpartum Urinary Incontinence.
NCT05194462
EXERT-BCN: an Exercise and Nutrition Regimen to Designed to Improve Body Composition After Treatment for Breast Cancer
NCT05978960
A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA
NCT05601128
Burst-Type Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease
NCT05753449
Non-invasive Vagal Neurostimulation (nVNS) for Traumatic Brain Injury (TBI)-Induced Acute Respiratory Distress
NCT04935697
Prospective Case-Control Study of Cardiovascular Changes in Pregnancy Related Hypertensive Disorders
NCT04713228
Does Supplementing Vitamin D Deficiency Affect Fusion Healing Rates in Elective Foot and Ankle Surgery?
NCT04450199
Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms
NCT04382391
Evaluation of Mepitel Film® in Preventing Epidermitis in Patients Receiving Radiation Therapy for Breast Cancer
NCT04149522
Immediate Weight-bearing Verses Non-Weight-bearing After Foot & Ankle Surgery
NCT03996707
Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH
NCT02734953
TECR & ECM Placement for Esophageal High Grade Dysplasia
NCT02396745
Medihoney and Santyl for Burn Injuries
NCT02250183
Deep Brain Stimulation Effects on Weight Change and Metabolic Rate
NCT01933113
Treating Post Traumatic Stress Disorder in Children Exposed to Domestic Violence
NCT00183326
Pharmacologic Treatment of PTSD in Sexually Abused Children
NCT00078767
Treatment of Post-Traumatic Stress Disorder (PTSD) in Sexually Abused Children
NCT00000383
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 3 |
| Phase 3 | 2 |
| Phase 4 | 1 |
Therapeutic Areas
What is open in the Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) pipeline
13 recruiting of 34 indexed (38% open); 9 completed (26%).
Phase mix: 3 late (III/IV) vs 7 early (I/II) (early-phase heavy).
Top condition: Cancer (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute): open-pipeline peers nationwide
Peers matched on 34 registered trials and 38% open enrollment, not the therapeutic-area sidebar.
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 34 trials (± recruiting share)
- American Regent · 34 trials · 0% recruiting
- Amicus Therapeutics · 34 trials · 15% recruiting
- Cochlear · 34 trials · 12% recruiting
- Emergent BioSolutions · 34 trials · 0% recruiting
Sponsors near 38% open enrollment (± trial volume)
- Children's National Research Institute · 38% recruiting · 92 trials
- Morehouse School of Medicine · 38% recruiting · 13 trials
- Northeastern University · 38% recruiting · 39 trials
- Thomas Hope · 38% recruiting · 13 trials
Related
What to do with this Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) page
34 registered trials is a research-attention snapshot, not an endorsement of Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) or any single study.
- 13 of Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cancer is the condition Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) pipeline card: 34 registered trials from official public datasets.Report a data error.